Eric Lucera, Editas Management, Editas: We are very fortunate to have the foundational Cas9, Cas12 license from Harvard MIT Broad. It’s a traditional university royalty rate that we think that ...

One is by out licensing the Cas9, Cas12 IP portfolio as we’ve done in the past with Vertex and then subsequently monetize that with DRI. The second way that we can do that is you’ve seen the ...

We really have three ways that we could bring in capital aside from the traditional ranges. One is by out licensing the Cas9, Cas12 IP portfolio as we’ve done in the past with Vertex and then ...

Technology Networks caught up with Professor Mazhar Adli to learn more about his research on the characterization of ...